After two doses, IL-2/CD40 slowed tumor growth rates in both age groups, although the effects in terms of tumor size (Figure 5B) and weights (Figure 5C) were more pronounced in young mice, relative to PBS diluent controls. Here, IL2 is linked to neoplasm.